EnVVeno Medical Corporation (NASDAQ:NVNO) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Headlines Articles Press releases EnVVeno Medical Corporation

Home
Companies
EnVVeno Medical Corporation

BRIEF

published on 11/26/2025 at 14:53, 8 days 14 hours ago

EnVVeno Medical to Join Live Virtual Investor Event

Webcast EnVVeno Medical Virtual Investor Event Robert Berman Medical Device Innovations
PRESS RELEASE

published on 11/26/2025 at 14:48, 8 days 14 hours ago

enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment
enVVeno Medical CEO, Robert Berman, to participate in a live webcast on December 3rd, providing corporate overview and answering questions. Focus on bioprosthetic solutions for deep venous disease

Webcast EnVVeno Medical Robert Berman Bioprosthetic Solutions Deep Venous Disease
BRIEF

published on 11/13/2025 at 23:05, 21 days 6 hours ago

EnVVeno Receives Unfavorable FDA Decision on VenoValve

VenoValve Chronic Venous Insufficiency EnVVe FDA Decision Medical Device Approval
PRESS RELEASE

published on 11/13/2025 at 23:00, 21 days 6 hours ago

enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve
enVVeno Medical Corporation receives unfavorable FDA decision on VenoValve, plans to focus on next-generation venous valve enVVe. Company has sufficient cash for operations into 2027. Severe CVI impacts millions in the U.S

VenoValve EnVVeno Medical Corporation Cash Reserves FDA Decision Severe CVI
BRIEF

published on 10/31/2025 at 13:10, 1 month 4 days ago

EnVVeno Medical Reports Q3 2025 Financial Results

EnVVeno Medical Cash Reserve FDA Appeal Q3 2025 Financial Results VenoValve Commercialization
PRESS RELEASE

published on 10/31/2025 at 13:05, 1 month 4 days ago

enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update
enVVeno Medical Corporation reports financial results for Q3 2025, with $31.0 million in cash and ongoing FDA engagement for VenoValve. CEO comments on capitalization and clinical progress

Financial Results VenoValve EnVVeno Medical Corporation FDA Engagement Clinical Progress
BRIEF

published on 09/26/2025 at 14:50, 2 months 8 days ago

EnVVeno Medical Engages in Virtual Investor Segment Amid FDA Appeal

Medical Devices EnVVeno Medical VenoValve Chronic Venous Insufficiency FDA Appeal
PRESS RELEASE

published on 09/26/2025 at 14:45, 2 months 8 days ago

enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment
enVVeno Medical Corporation announces CEO Robert Berman's participation in a Virtual Investor segment discussing the supervisory appeal for VenoValve® with FDA

FDA EnVVeno Medical VenoValve Virtual Investor Supervisory Appeal
BRIEF

published on 09/15/2025 at 14:50, 2 months 19 days ago

EnVVeno Medical Pursues FDA Supervisory Appeal

EnVVeno Medical VenoValve Chronic Venous Insufficiency Regulatory Process FDA Appeal
PRESS RELEASE

published on 09/15/2025 at 14:45, 2 months 19 days ago

enVVeno Medical Updates Regulatory Status of VenoValve(R)
enVVeno Medical Corporation to file supervisory appeal with FDA regarding not-approvable letter for VenoValve® submission to treat deep venous CVI, aiming to bring innovative solution to patients

FDA EnVVeno Medical Corporation VenoValve® Deep Venous Disease Supervisory Appeal

Accesswire

Published on 12/05/2025 at 02:35, 2 hours 51 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 2 hours 56 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 4 hours 26 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 21 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 26 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 1 hour 56 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 35 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 1 minute ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 11 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 15 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 11 hours 26 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 41 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 42 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 25 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE